ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676944 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676944; 2) Community: the network communities that were significantly associated with the response to NSC 676944; 3) Molecule: the relationships between components within communities and NSC 676944; 4) MDR: the compounds that were significantly associated with the NSC 676944.

NSC Compound Enrichment Correlation
NSC 639976 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride 0.00479683626511392 -0.01442502
NSC 674098 2-Acetylimidazo[4,5-b]pyridin 4 sec-butyl 3thiosemi-carbazone 0.00479683626511392 0.37462112
NSC 339705 5H-Indeno[1,2-c]isoquinoline-5,11(6H)-dione, 6-(2-hydroxyethyl)- 0.00645628049634952 0.41459837
NSC 651654 Null 0.00645628049634952 0.15868771
NSC 672305 Null 0.00645628049634952 0.070532763
NSC 689627 Null 0.00645628049634956 0.19139194
NSC 757113 METHOTREXATE(+/-) 0.00662388971299133 0.39303185
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.00662388971299138 0.39791159
NSC 305799 2,4-Quinazolinediamine, 6-[[4-(dimethylamino)phenyl]thio]- 0.00662388971299138 0.32074081
NSC 4320 .beta.-k-Strophanthin 0.00662388971299138 0.36392847
Total:56  Current:8    [First] [Prev] [Next] [Last]